Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data.
about
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectThrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature.Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms.Amiodarone-associated optic neuropathy: a critical review.Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectComparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.Signal detection methodologies to support effective safety management.Leukotriene receptor antagonists and Churg-Strauss Syndrome: an association with relevance to dermatopathology?Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area.Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.Life-threatening dermatologic adverse events in oncologyChurg-Strauss syndrome associated with montelukast therapy.A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.Evaluation of disproportionality safety signaling applied to healthcare databases.
P2860
Q27026618-9FEA963A-D710-4135-A3BD-DFC8B6F32D0CQ30379316-4B0A97BB-10D9-4DAB-9FD0-25A8CEA5C8F2Q33387169-719AFDFA-ADEC-451C-80F6-45BAB05CD7D0Q35878060-85AF6248-2565-4C90-BE75-592F703F3598Q36678173-D08224E0-AC8D-4305-B9D7-DFB685BA3A85Q36771146-7928ECD2-327C-4A47-A31F-65BB2B2D80F1Q36905865-05E4166C-F0C0-4D5E-9519-235A15285C0CQ37157937-8E2570D0-C327-47A8-84AD-F045A74B28E3Q37319463-21789994-9749-4A77-8E3D-9F59F768CF8FQ37689558-2F4F7A07-4A8A-4063-90CE-19B0ACBAEBC6Q38590850-274F5992-451E-4C7C-8603-39735DA1D965Q41869634-17A321F5-601E-4604-AB15-A9402E58C91EQ43297955-E1DAC50F-801F-4A5C-89A0-C29609DF8B85Q44018531-747E9F2C-36D5-4FA9-A412-90C0EC078CA3Q46828458-A0780889-EC3F-42EA-8EDD-13EC8592F07EQ51495533-CA28B134-BE3F-4A78-9B6C-1A6B0EE58944Q53128866-FCA1A830-1074-48EB-9F88-44C2A8CBE74B
P2860
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Association of asthma therapy ...... stmarketing surveillance data.
@ast
Association of asthma therapy ...... stmarketing surveillance data.
@en
type
label
Association of asthma therapy ...... stmarketing surveillance data.
@ast
Association of asthma therapy ...... stmarketing surveillance data.
@en
prefLabel
Association of asthma therapy ...... stmarketing surveillance data.
@ast
Association of asthma therapy ...... stmarketing surveillance data.
@en
P2093
P1476
Association of asthma therapy ...... stmarketing surveillance data.
@en
P2093
David Fram
Eric T Smith
Harold Nelson
June S Almenoff
Xionghu Yang
P304
P356
10.1016/S0149-2918(04)90181-6
P577
2004-07-01T00:00:00Z